Yamiz Tablets

Adult dose

This medication should be taken for 24 days, with 24 pink active tablets taken once daily, followed by 4 days of taking white placebo tablets. It can be started on the first day of the menstrual cycle or on the first Sunday after the menstrual cycle begins. It is preferable to take it at the same time each day and can be taken regardless of meals. If this is the first time taking this medication and the hormonal contraceptive was not used last month, the first day of use should be the first day of menstruation.

This medication can significantly increase the risk of serious cardiovascular side effects, particularly thrombosis, in women who smoke. Women aged 35 years and older who smoke 15 or more cigarettes a day should not take this medication. The drospirenone component contained in this drug may cause hyperkalemia, an increase in potassium levels in the blood; therefore, patients with renal function, liver function, or adrenal function issues should not take it. Furthermore, if taking other medications that can increase blood potassium levels, potassium levels should be checked during the first cycle of use. This drug is used for the treatment of moderate acne in women who have started menstruating after the age of 14 and should only be taken if oral contraceptives are wanted for birth control. Do not take it before the onset of menstruation. Patients with cardiovascular risks, especially if thrombosis-related adverse reactions occur, should stop taking the medication immediately. It should also be stopped at least 4 weeks prior to surgery and for 2 weeks after surgery. Women who do not breastfeed after childbirth should not start taking this medication within 4 weeks after delivery. This drug may possess a higher risk of venous thromboembolism compared to oral contraceptives containing levonorgestrel or other progestins, so individual thromboembolism risk should be assessed before taking. The following patients should not take this medication: - If there are known or suspected estrogen-dependent tumors - In cases of thrombogenic disease history or tendencies to form clots - Patients with cardiovascular or cerebrovascular diseases - Patients with severe hypertension, severe liver dysfunction, moderate or severe kidney dysfunction, or adrenal dysfunction - Pregnant women or those who may become pregnant, and nursing mothers - If allergic to any component of this medication - In cases of specific hereditary diseases such as lactose intolerance Additionally, women over 40 years of age and patients with a history of epilepsy, depression, breast cancer, renal and mental insufficiency, hyperlipidemia, gallbladder disease, endometriosis, asthma, and headaches must take this medication with caution. Possible side effects while taking this drug include thrombosis, myocardial infarction, cerebrovascular accident, hypertension, gallbladder disease, liver tumors, gastrointestinal symptoms, uncontrolled bleeding, menstrual changes, breast pain, weight changes, depression, allergic reactions, and more. If symptoms of thrombosis or cardiovascular problems occur during takin, immediate consultation with healthcare practitioners is essential, along with regular check-ups, blood pressure monitoring, and breast and pelvic examinations to continuously evaluate health status. This medication may interact with other drugs, so be sure to inform healthcare providers of any medications being taken.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by fever, blisters, skin peeling, pain in the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, cough with fever, skin or eyes turning yellow (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urinary problems

Mild side effects

Nausea, vomiting, gastrointestinal symptoms (abdominal cramps and distention), uncontrolled bleeding, spotting, changes in menstrual cycle, amenorrhea, temporary infertility after discontinuation, edema, persistent melasma, breast changes (breast pain, enlargement, milk secretion, tenderness, discharge), weight changes (increase or decrease), changes in the uterus, decreased milk after childbirth, migraine, rash (allergic), mental depression, decreased glucose tolerance, vaginal candidiasis

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the efficacy of the drug for a longer period.

Appearance

Placebo tablet - white or off-white, round, biconvex film-coated tablet Active tablet - pink, round, biconvex film-coated tablet

Package unit

28 tablets/box [28 tablets/PTP]